Kanagawa, Japan

Yoshito Terao

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 8.1

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Osaka, JP (2013 - 2014)
  • Fujisawa, JP (2021)
  • Kanagawa, JP (2014 - 2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovations of Yoshito Terao

Introduction

Yoshito Terao is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the brain. With a total of nine patents to his name, Terao's work has the potential to impact the treatment of various sleep disorders.

Latest Patents

Among his latest innovations, Terao has developed a heterocyclic compound that exhibits orexin type 2 receptor agonist activity. This compound, represented by a specific formula, is designed to be useful as an agent for the prophylaxis or treatment of narcolepsy. The significance of this invention lies in its potential to improve the quality of life for individuals suffering from this condition.

Career Highlights

Throughout his career, Yoshito Terao has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals, LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations

Terao has collaborated with esteemed colleagues, including Rei Okamoto and Nobuyuki Matsunaga. These partnerships have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Yoshito Terao's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for new treatments and innovations in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…